Failure to Perceive Increased Risk of Fracture in Women >= 55 Years. The Global Longitudinal Registry of Osteoporosis in Women

Failure to Perceive Increased Risk of Fracture in Women >= 55 Years. The Global Longitudinal Registry of Osteoporosis in Women

Bibliográfalaš dieđut
Váldodahkkit:	Siris, E, Diez-Perez, A, Boonen, S, Cooper, C, LaCroix, A, Watts, N, Saag, K, Silverman, S, Dedrick, R, Greenspan, S
Materiálatiipa:	Conference item
Almmustuhtton:	2008

Geahča maid

Failure to perceive increased risk of fracture in women aged 55 years and older. The global longitudinal study of osteoporosis in women
Dahkki: Adami, S, et al.
Almmustuhtton: (2009)

Failure to perceive increased risk of fracture in women aged 55 years and older. The global longitudinal study of osteoporosis in women
Dahkki: Adami, S, et al.
Almmustuhtton: (2009)

Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW)
Dahkki: Siris, E, et al.
Almmustuhtton: (2010)

Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW).
Dahkki: Siris, E, et al.
Almmustuhtton: (2011)

FAILURE TO PERCEIVE INCREASED RISK OF FRACTURE IN WOMEN 55 YEARS AND OLDER. THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN
Dahkki: Cooper, C, et al.
Almmustuhtton: (2009)

The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design.
Dahkki: Hooven, F, et al.
Almmustuhtton: (2009)

Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW).
Dahkki: Díez-Pérez, A, et al.
Almmustuhtton: (2011)

Obesity, health-care utilization, and health-related quality of life after fracture in postmenopausal women: Global Longitudinal Study of Osteoporosis in Women (GLOW).
Dahkki: Compston, J, et al.
Almmustuhtton: (2014)

Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women.
Dahkki: Gehlbach, S, et al.
Almmustuhtton: (2012)

Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women.
Dahkki: Pfeilschifter, J, et al.
Almmustuhtton: (2012)

Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women
Dahkki: Pfeilschifter, J, et al.
Almmustuhtton: (2011)

Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW).
Dahkki: Díez-Pérez, A, et al.
Almmustuhtton: (2014)

FRACTURE INCIDENCE IN OBESE POSTMENOPAUSAL WOMEN: THE GLOBAL STUDY OF OSTEOPOROSIS IN WOMEN (GLOW)
Dahkki: Compston, J, et al.
Almmustuhtton: (2012)

Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).
Dahkki: Roux, C, et al.
Almmustuhtton: (2012)

Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women.
Dahkki: Adachi, J, et al.
Almmustuhtton: (2010)

Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).
Dahkki: Compston, J, et al.
Almmustuhtton: (2014)

Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)
Dahkki: Dennison, E, et al.
Almmustuhtton: (2012)

When, where and how osteoporosis-associated fractures occur: an analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW)
Dahkki: Costa, A, et al.
Almmustuhtton: (2013)

Characteristics associated with anti-osteoporosis medication use: Data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort
Dahkki: Guggina, P, et al.
Almmustuhtton: (2012)

Characteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort.
Dahkki: Guggina, P, et al.
Almmustuhtton: (2012)

When, where and how osteoporosis-associated fractures occur: an analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
Dahkki: Aline G Costa, et al.
Almmustuhtton: (2013-01-01)

Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW).
Dahkki: FitzGerald, G, et al.
Almmustuhtton: (2014)

Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW)
Dahkki: Ioannidis, G, et al.
Almmustuhtton: (2012)

Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW).
Dahkki: Ioannidis, G, et al.
Almmustuhtton: (2013)

Frailty and fracture, disability, and falls: a multiple country study from the global longitudinal study of osteoporosis in women.
Dahkki: Tom, SE, et al.
Almmustuhtton: (2013)

Distribution of risk factors for fracture in women with and without a fracture history: A regional comparison. The global longitudinal registry of osteoporosis in women
Dahkki: Adachi, J, et al.
Almmustuhtton: (2008)

DISEASE-SPECIFIC PERCEPTION OF FRACTURE RISK AND INCIDENT FRACTURE RATES AMONG POSTMENOPAUSAL WOMEN: THE GLOW REGISTRY
Dahkki: Gregson, C, et al.
Almmustuhtton: (2013)

RISK FACTORS FOR FRAGILITY FRACTURE IN A MULTIRACIAL COHORT OF US WOMEN. THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN
Dahkki: Silverman, S, et al.
Almmustuhtton: (2009)

REGIONAL DIFFERENCES IN THE MANAGEMENT OF OSTEOPOROSIS. THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN
Dahkki: Chapurlat, R, et al.
Almmustuhtton: (2009)

Frailty and fracture, disability, and falls: A multiple country study from the global longitudinal study of osteoporosis in women
Dahkki: Tom, SE, et al.
Almmustuhtton: (2013)

DISTRIBUTION OF RISK FACTORS FOR FRACTURE IN WOMEN WITH AND WITHOUT A FRACTURE HISTORY: A REGIONAL COMPARISON. THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN
Dahkki: Diez-Perez, A, et al.
Almmustuhtton: (2009)

REASONS FOR STOPPING ANTI-OSTEOPOROSIS MEDICATIONS AMONG POSTMENOPAUSAL WOMEN: THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN
Dahkki: Hooven, F, et al.
Almmustuhtton: (2010)

Obesity is not protective against fracture in postmenopausal women: GLOW.
Dahkki: Compston, J, et al.
Almmustuhtton: (2011)

RISK FACTOR CHARACTERISTICS OF WOMEN WITH INCIDENT FRACTURES: THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN
Dahkki: Hooven, F, et al.
Almmustuhtton: (2010)

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.
Dahkki: Rizzoli, R, et al.
Almmustuhtton: (2011)

Predicting fractures in an international cohort using risk factor algorithms without BMD.
Dahkki: Sambrook, P, et al.
Almmustuhtton: (2011)

FRACTURES IN OBESE POSTMENOPAUSAL WOMEN: PREVALENCE, SKELETAL LOCATION AND RISK FACTORS
Dahkki: Compston, J, et al.
Almmustuhtton: (2011)

Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.
Dahkki: Gregson, C, et al.
Almmustuhtton: (2014)

EFFECT OF CO-MORBIDITIES ON FRACTURE RISK: FINDINGS FROM THE GLOW STUDY
Dahkki: Dennison, E, et al.
Almmustuhtton: (2011)

Patterns of anti-osteoporosis medication use among women at high risk of fracture: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
Dahkki: Stephen Gehlbach, et al.
Almmustuhtton: (2013-01-01)